Search all medical codes

Other systemic atrophy primarily affecting central nervous system in neoplastic disease

ICD10CM code

Medical Policies and Guidelines for Other systemic atrophy primarily affecting central nervous system in neoplastic disease

Related policies from health plans

Autonomic Nerve Function Testing - (0506)
Autonomic Nerve Function Testing - (0506)
Autonomic Nerve Function Testing - (0506)
Electrodiagnostic Testing (EMG/NCV) - (CPG129)
Therapeutic Apheresis
Orthotic Devices and Shoes - (0543)
CG-MED-68 Therapeutic Apheresis

Similar Codes


ICD10CM codes

G13.1 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease
G13.8 - Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
G13 - Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
G13.2 - Systemic atrophy primarily affecting the central nervous system in myxedema
D33.7 - Benign neoplasm of other specified parts of central nervous system
C72.9 - Malignant neoplasm of central nervous system, unspecified
G31.89 - Other specified degenerative diseases of nervous system
G13.0 - Paraneoplastic neuromyopathy and neuropathy
G96.89 - Other specified disorders of central nervous system
G96.8 - Other specified disorders of central nervous system

HCPCS codes

G8947 - One or more neuropsychiatric symptoms
G9842 - Patient has metastatic disease at diagnosis
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G9535 - Patients with a normal neurological examination
G9420 - Specimen site other than anatomic location of lung or is not classified as primary non-small cell lu
G8721 - Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documente
G8749 - Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or
G9555 - Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple en
G9012 - Other specified case management service not elsewhere classified
G8927 - Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer

CPT4 codes

88239 - Tissue culture for neoplastic disorders; solid tumor
64640 - Destruction by neurolytic agent; other peripheral nerve or branch
64999 - Unlisted procedure, nervous system
88237 - Tissue culture for neoplastic disorders; bone marrow, blood cells
61790 - Creation of lesion by stereotactic method, percutaneous, by neurolytic agent (eg, alcohol, thermal,
61616 - Resection or excision of neoplastic, vascular or infectious lesion of base of posterior cranial foss
88230 - Tissue culture for non-neoplastic disorders; lymphocyte
81437 - Hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, m
64680 - Destruction by neurolytic agent, with or without radiologic monitoring; celiac plexus
61615 - Resection or excision of neoplastic, vascular or infectious lesion of base of posterior cranial foss